Loading organizations...
Loading organizations...
Developing novel DNA repair inhibitors targeting tumor microenvironments.
Cybrexa Therapeutics has raised $44.4M across 3 funding rounds.
Cybrexa Therapeutics has raised $44.4M in total across 3 funding rounds.
Cybrexa Therapeutics has raised $44.4M in total across 3 funding rounds.
Cybrexa Therapeutics's investors include Elm Street Ventures, Kevin Rakin, Connecticut Innovations, Cycle Venture Partners, HighCape Capital.
Cybrexa Therapeutics has raised $44.4M across 3 funding rounds. Most recently, it raised $25.0M Series B in March 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 11, 2021 | $25.0M Series B | Elm Street Ventures, Kevin Rakin | |
| Jun 20, 2019 | $13.4M Series B | Connecticut Innovations, Cycle Venture Partners, HighCape Capital | |
| Jun 16, 2017 | $6.0M Series B | Connecticut Innovations, HighCape Capital |